Morgan Stanley Tango Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 341,977 shares of TNGX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

341,977

Previous 243,369 40.52%

Holding current value

$1.04 Million

Previous $2.09 Million 26.1%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.36 - $11.93 $725,754 - $1.18 Million	98,608 Added 40.52%	341,977 $2.63 Million
Q2 2024 Oct 17, 2024	BUY	$6.66 - $10.15 $425,241 - $648,077	63,850 Added 35.57%	243,369 $2.09 Million
Q2 2024 Aug 14, 2024	BUY	$6.66 - $10.15 $425,241 - $648,077	63,850 Added 35.57%	243,369 $2.09 Million
Q1 2024 Oct 17, 2024	SELL	$7.51 - $12.88 $479,513 - $822,388	-63,850 Reduced 26.24%	179,519 $1.43 Million
Q1 2024 Aug 16, 2024	BUY	$7.51 - $12.88 $271,201 - $465,122	36,112 Added 25.18%	179,519 $1.43 Million
Q1 2024 May 15, 2024	BUY	$7.51 - $12.88 $271,201 - $465,122	36,112 Added 25.18%	179,519 $1.43 Million
Q4 2023 Aug 16, 2024	SELL	$6.52 - $12.01 $651,752 - $1.2 Million	-99,962 Reduced 41.07%	143,407 $1.42 Million
Q4 2023 Feb 13, 2024	SELL	$6.52 - $12.01 $325,458 - $599,503	-49,917 Reduced 25.82%	143,407 $1.42 Million
Q3 2023 Nov 15, 2023	BUY	$2.93 - $11.26 $407,650 - $1.57 Million	139,130 Added 256.73%	193,324 $2.18 Million
Q2 2023 Aug 14, 2023	SELL	$2.67 - $4.7 $57,129 - $100,565	-21,397 Reduced 28.31%	54,194 $179,000
Q1 2023 May 15, 2023	BUY	$3.76 - $8.06 $175,486 - $376,176	46,672 Added 161.39%	75,591 $298,000
Q4 2022 Feb 14, 2023	BUY	$3.41 - $8.29 $19,617 - $47,692	5,753 Added 24.83%	28,919 $209,000
Q3 2022 Nov 14, 2022	BUY	$3.25 - $5.46 $15,385 - $25,847	4,734 Added 25.68%	23,166 $83,000
Q2 2022 Oct 27, 2022	BUY	$3.86 - $8.01 $10,487 - $21,763	2,717 Added 17.29%	18,432 $84,000
Q2 2022 Aug 15, 2022	BUY	$3.86 - $8.01 $10,487 - $21,763	2,717 Added 17.29%	18,432 $84,000
Q1 2022 Oct 27, 2022	SELL	$7.01 - $10.94 $19,046 - $29,723	-2,717 Reduced 14.74%	15,715 $119,000
Q1 2022 May 13, 2022	BUY	$7.01 - $10.94 $48,214 - $75,245	6,878 Added 77.83%	15,715 $119,000
Q4 2021 Feb 14, 2022	BUY	$9.55 - $14.29 $66,754 - $99,887	6,990 Added 378.45%	8,837 $96,000
Q3 2021 Nov 15, 2021	BUY	$9.56 - $17.3 $17,657 - $31,953	1,847 New	1,847 $24,000

Others Institutions Holding TNGX

# of Institutions

123

Shares Held

91.7M

Call Options Held

3.1K

Put Options Held

1.5K

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $268M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account